ORTHOCELL LIMITED

0.82%

$1.21

Market Cap $294.9M

Technology Scientific & Technical Instruments

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is a sterile, resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen scaffold used in peripheral nerve repair. OrthoACI or autologous chondrocyte implantation is used for the treatment of articular cartilage defects in the knee and ankle. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. LATEST: Race Oncology Accelerates Game-Changing Cancer Drug.

Latest Threads

Tag

Subject

OCC

OCC Trading

40 41 42

12:08

2.4K

895K

12:08

Last post Speckled

2.4K

895K

OCC

Media thread

17 18 19

07/08/25

1.1K

448K

07/08/25

Last post MikesLM

1.1K

448K

OCC

OCC Broker Data

3 4 5

06/08/25

248

118K

06/08/25

Last post Superchicken

248

118K

OCC

Ann: Orthocell Announces First US Remplir Sales Revenue

06/08/25

11K

06/08/25

Last post MikesLM

11K

OCC

Ann: CelGro Facilitates Lymphatic Vessel Regeneration

04/08/25

15K

04/08/25

Last post bedger

15K

OCC

Ann: CelGro Facilitates Lymphatic Vessel Regeneration Updated

02/08/25

1.2K

02/08/25

Last post scolloymore

1.2K

OCC

Ann: Option Terms and Conditions

29/07/25

4.2K

29/07/25

Last post Connex

4.2K

OCC

OCC chart

42 43 44

29/07/25

2.5K

1.3M

29/07/25

Last post Polyphemus

2.5K

1.3M

See All Discussions

Timeline

Notification regarding unquoted securities - OCC
28 Jul 18:11	Share

Option Terms and Conditions
28 Jul 17:14	Share

Proposed issue of securities - OCC
28 Jul 17:12	Share

Final Director's Interest Notice
25 Jul 09:31	Share

Proposed issue of securities - OCC
25 Jul 09:30	Share

Orthocell Announces Changes to Board of Directors
25 Jul 09:04	Share

Notification of cessation of securities - OCC
14 Jul 08:29	Share

Cleansing Notice
10 Jul 16:20	Share

Application for quotation of securities - OCC
10 Jul 16:18	Share

Orthocell Announces First US Remplir Sales Revenue
10 Jul 09:03	Share

Quarterly Activity Report & Appendix 4C
09 Jul 09:00	Share

Remplir US Rollout & 1st Surgery Investor Update
02 Jul 12:46	Share

Orthocell Bolsters Leadership with Key Hires
02 Jul 09:03	Share

Record Revenue of $2.73m in June 25 Quarter up 22.8% QoQ
01 Jul 09:03	Share

Investor Webinar
27 Jun 09:50	Share

First Surgical Use of Remplir in US$1.6 Billion US Market
27 Jun 09:01	Share

Compelling Data Highlights Remplir Competitive Advantage
19 Jun 08:59	Share

Cleansing Notice
10 Jun 16:48	Share

Application for quotation of securities - OCC
10 Jun 16:45	Share

Remplir Approved to Commence Sales in the Hong Kong Market
12 May 08:56	Share

12 Distributors Signed for Remplir Covering 21 States in US
09 May 08:58	Share

Remplir Approved to Commence Sales in US$75m Canadian Market
30 Apr 09:08	Share

Replacement Trading Halt
29 Apr 11:52	Share

Trading Halt
29 Apr 11:23	Share

Pause in Trading
29 Apr 11:04	Share

Remplir Approved to Commence Sales in US$84M Thai Market
28 Apr 08:55	Share

First US Distributors Signed for Remplirs US$1.6B market
23 Apr 09:41	Share

Quarterly Activity Report & Appendix 4C
14 Apr 08:52	Share

Remplir Regulatory Application Submitted for Hong Kong
10 Apr 09:00	Share

Regulatory Approval for Striate in US$65M Brazilian Market
09 Apr 09:19	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.21		Change -0.010(0.82%)		Mkt cap ! $294.9M

Open	High	Low	Value	Volume
$1.22	$1.22	$1.20	$435.9K	362.0K

Buyers (Bids)

No.	Vol.	Price($)
11	16885	$1.20

Sellers (Offers)

Price($)	Vol.	No.
$1.21	2331	4

View Market Depth

No.	Vol.	Price($)
10	8585	1.200
6	18805	1.195
11	46303	1.190
4	7909	1.185
10	82588	1.180

Price($)	Vol.	No.
1.210	7618	5
1.215	14633	4
1.220	15705	6
1.225	2930	1
1.230	20000	1

Last trade - 14.18pm 11/08/2025 (20 minute delay)


Last $1.21		Change -0.010 ( 1.22 %)
Open	High	Low	Volume
$1.21	$1.22	$1.20	101888
Last updated 14.13pm 11/08/2025 ?

OCC (ASX) Chart

ORTHOCELL LIMITED

Latest Threads

Timeline

Featured News

Latest Videos

Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come

04 Dec 2024 15:54 (AEDT)

Latest Articles

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Orthocell (ASX:OCC) shares notched upwards on Friday as the company announced its nerve repair product has been...

Orthocell sees US Remplir sales on immediate horizon as distro deal locked in

Orthocell (ASX:OCC) has locked in a U.S. distributor deal for its flagship product and biotech punter favourite Remplir, leaving the company confident U.S. sales are about to kick off. Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from througho...

Orthocell spikes 7% after clearing huge US hurdle for its nerve repair product

The stock’s bull run over the last two months has seen its share price more than double as investors eye the lucrative $1.6B nerve repair market in the US.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News